The history of qing hao {A figure is presented} in the Chinese materia medica

Institute of Social and Cultural Anthropology, University of Oxford, 51 Banbury Road, Oxford OX2 6PE, UK.
Transactions of the Royal Society of Tropical Medicine and Hygiene (Impact Factor: 1.84). 07/2006; 100(6):505-8. DOI: 10.1016/j.trstmh.2005.09.020
Source: PubMed


Artemisinin is currently used for treating drug-resistant malaria. It is found in Artemisia annua and also in A. apiacea and A. lancea. Artemisia annua and A. apiacea were known to the Chinese in antiquity and, since they were easily confused with each other, both provided plant material for the herbal drug qing hao (blue-green hao). This article shows, however, that since at least the eleventh century Chinese scholars recognized the difference between the two species, and advocated the use of A. apiacea, rather than A. annua for 'treating lingering heat in joints and bones' and 'exhaustion due to heat/fevers'. The article furthermore provides a literal translation of the method of preparing qing hao for treating intermittent fever episodes, as advocated by the eminent physician Ge Hong in the fourth century CE. His recommendation was to soak the fresh plant in cold water, wring it out and ingest the expressed juice in its raw state. Both findings may have important practical implications for current traditional usage of the plant as an antimalarial: rather than using the dried leaves of A. annua in warm infusions, it suggests that fresh juice extraction from A. apiacea may improve efficacy.

92 Reads
  • Source
    • "Artemisia annua has been used as a medicinal plant in China for a long time (Hsu 2006; Miller and Su 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Artemisinin is widely used as an antimalarial drug around the world. Artemisinic aldehyde Δ11(13) reductase (DBR2) is a key enzyme which reduces artemisinic aldehyde to dihydroartemisinic aldehyde in the biosynthesis of artemisinin. In this study, two fragments encompassing a putative promoter of DBR2, designated as DBR2pro1 and DBR2pro2, were isolated using genomic DNA walking. The transcription start site and the putative cis-elements of each version of promoter were predicted using bioinformatic analysis. In order to study the function of the cloned promoter, Artemisia annua was transformed with β-glucuronidase (GUS) reporter gene driven by DBR2pro1 and DBR2pro2, respectively. GUS staining results demonstrated that both DBR2pro1 and DBR2pro2 were strongly expressed in glandular secretory trichomes (GSTs) of leaf primordia and flower buds, but were not obviously expressed in roots, stems, old leaves, and fully developed flowers, thus indicating that the two versions of promoter were functional and specifically expressed in GSTs.
    Plant Molecular Biology Reporter 02/2014; 32(1). DOI:10.1007/s11105-013-0603-2 · 1.66 Impact Factor
  • Source
    • "In the present investigation, we focused on the last of these four aspects and analyzed the synergistic interaction of a compound derived from Chinese medicine (artesunate) and a compound established in Western academic medicine (captopril). Artemisia annua L. (Sweet Wormwood, qinghao) is an herb used in traditional Chinese medicine to treat fever and chills [15, 16]. In the 1970s, the active principle of the plant, artemisinin, has been identified as an antimalarial sesquiterpene [17]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Inhibition of angiogenesis represents one major strategy of cancer chemotherapy. In the present investigation, we investigated the synergism of artesunate and captopril to inhibit angiogenesis. Artesunate is an antimalarial derivative of artemisinin from the Chinese medicinal plant, Artemisia annua L., which also reveals profound anticancer activity in vitro and in vivo. Captopril is an angiotensin I-converting (ACE) inhibitor, which is well established in Western academic medicine. Both compounds inhibited migration of human umbilical vein endothelial cells (HUVECs) in vitro. The combination of both drugs resulted in synergistically inhibited migration. Whereas artesunate inhibited HUVEC growth in the XTT assay, captopril did not, indicating independent modes of action. We established a chorioallantoic membrane (CAM) assay of quail embryos (Coturnix coturnix L.) and a computer-based evaluation routine for quantitative studies on vascularization processes in vivo. Artesunate and captopril inhibited blood vessel formation and growth. For the first time, we demonstrated that both drugs revealed synergistic effects when combined. These results may also have clinical impact, since cardiovascular diseases and cancer frequently occur together in older cancer patients. Therefore, comorbid patients may take advantage, if they take captopril to treat cardiovascular symptoms and artesunate to treat cancer.
    Evidence-based Complementary and Alternative Medicine 10/2013; 2013(454783):454783. DOI:10.1155/2013/454783 · 1.88 Impact Factor
  • Source
    • "Ge Hong, a famous physician in TCM, described a herbal prescription against “intermittent fevers” (malaria) in one of his written works. In essence, fresh plant materials of Qing-Hao were soaked in cold water and then squeezed for juice for oral intake [83]. Qing-Hao is native to temperate Asia, including Korea, Japan, Vietnam (north), Myanmar, India (north), and Nepal. "
    [Show abstract] [Hide abstract]
    ABSTRACT: With tens of thousands of plant species on earth, we are endowed with an enormous wealth of medicinal remedies from Mother Nature. Natural products and their derivatives represent more than 50% of all the drugs in modern therapeutics. Because of the low success rate and huge capital investment need, the research and development of conventional drugs are very costly and difficult. Over the past few decades, researchers have focused on drug discovery from herbal medicines or botanical sources, an important group of complementary and alternative medicine (CAM) therapy. With a long history of herbal usage for the clinical management of a variety of diseases in indigenous cultures, the success rate of developing a new drug from herbal medicinal preparations should, in theory, be higher than that from chemical synthesis. While the endeavor for drug discovery from herbal medicines is "experience driven," the search for a therapeutically useful synthetic drug, like "looking for a needle in a haystack," is a daunting task. In this paper, we first illustrated various approaches of drug discovery from herbal medicines. Typical examples of successful drug discovery from botanical sources were given. In addition, problems in drug discovery from herbal medicines were described and possible solutions were proposed. The prospect of drug discovery from herbal medicines in the postgenomic era was made with the provision of future directions in this area of drug development.
    Evidence-based Complementary and Alternative Medicine 03/2013; 2013:627375. DOI:10.1155/2013/627375 · 1.88 Impact Factor
Show more


92 Reads
Available from